Newly Diagnosed Glioblastoma

April 12, 2024

Prospective Randomized Placebo-Controlled Trial of SurVaxM Plus Adjuvant Temozolomide for Newly Diagnosed Glioblastoma (SURVIVE)

Schedule an Appointment

Select an appointment date and time from available spots listed below.